U.S. flag

An official website of the United States government

NM_004183.4(BEST1):c.744C>A (p.Phe248Leu) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 13, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001894912.6

Allele description [Variation Report for NM_004183.4(BEST1):c.744C>A (p.Phe248Leu)]

NM_004183.4(BEST1):c.744C>A (p.Phe248Leu)

Gene:
BEST1:bestrophin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q12.3
Genomic location:
Preferred name:
NM_004183.4(BEST1):c.744C>A (p.Phe248Leu)
HGVS:
  • NC_000011.10:g.61958175C>A
  • NG_009033.1:g.13292C>A
  • NM_001139443.2:c.564C>A
  • NM_001300786.2:c.564C>A
  • NM_001300787.2:c.564C>A
  • NM_001363591.2:c.426C>A
  • NM_001363592.1:c.744C>A
  • NM_001363593.2:c.-432C>A
  • NM_004183.4:c.744C>AMANE SELECT
  • NP_001132915.1:p.Phe188Leu
  • NP_001287715.1:p.Phe188Leu
  • NP_001287716.1:p.Phe188Leu
  • NP_001350520.1:p.Phe142Leu
  • NP_001350521.1:p.Phe248Leu
  • NP_004174.1:p.Phe248Leu
  • NC_000011.9:g.61725647C>A
  • NR_134580.2:n.857C>A
Protein change:
F142L
Links:
dbSNP: rs2134445000
NCBI 1000 Genomes Browser:
rs2134445000
Molecular consequence:
  • NM_001363593.2:c.-432C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001139443.2:c.564C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300786.2:c.564C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300787.2:c.564C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363591.2:c.426C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363592.1:c.744C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004183.4:c.744C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134580.2:n.857C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

  • Indians, South American
    Indians, South American
    Members of indigenous South American populations with pre-colonial contact origins.<br/>
    MeSH
  • Medication Reconciliation
    Medication Reconciliation
    The formal process of obtaining a complete and accurate list of each patient's current home medications including name, dosage, frequency, and route of administration, and com...<br/>Year introduced: 2011
    MeSH
  • Comprehensive Dental Care
    Comprehensive Dental Care
    Providing for the full range of dental health services for diagnosis, treatment, follow-up, and rehabilitation of patients.<br/>Year introduced: 1973
    MeSH
  • Central Asian People
    Central Asian People
    People native to or inhabitants of CENTRAL ASIA including KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN and UZBEKISTAN.<br/>Year introduced: 2023
    MeSH
  • HAO1 hydroxyacid oxidase 1 [Canis lupus familiaris]
    HAO1 hydroxyacid oxidase 1 [Canis lupus familiaris]
    Gene ID:485774
    Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002137184Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Feb 13, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002137184.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. This variant has not been reported in the literature in individuals with BEST1-related conditions. This sequence change replaces phenylalanine with leucine at codon 248 of the BEST1 protein (p.Phe248Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024